中国医药：拟3.02亿元收购金穗科技100%股权

Core Viewpoint - China National Pharmaceutical Group plans to acquire 100% equity of Jinsui Technology for 302 million yuan, which constitutes a related party transaction [1] Group 1: Acquisition Details - The acquisition will be conducted in cash amounting to 302 million yuan [1] - Jinsui Technology will become a wholly-owned subsidiary of China National Pharmaceutical Group after the transaction [1] - The seller, New Star Group, is a wholly-owned subsidiary of the controlling shareholder, General Technology Group [1] Group 2: Business Operations - Jinsui Technology specializes in e-commerce operation services, covering personal health consumer products and the broader health sector [1] - The company has established partnerships with well-known domestic and international brands such as Philips and Omron [1] - The core business currently focuses on brand authorization and distribution of Philips personal health consumer products [1]